FULC insider trading — Fulcrum Therapeutics, Inc.
Over the last 90 days, insiders at Fulcrum Therapeutics, Inc. (FULC) made 2 open-market purchases worth $595K and 0 open-market sales worth $0, making them net buyers by $595K. The largest purchase was by Tang Kevin, Tang Capital Management Llc (10% Owner), who bought 116,671 shares for $415K on Jul 16, 2026.
Updated Oct 16, 2026.
Recent FULC insider transactions
Every Form 4 filed by Fulcrum Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Tang Kevin, Tang Capital Management Llc | 10% Owner | P · Purchase | Indirect | 50,945 | $3.52 | $179K | Form 4 |
| Jul 16, 2026 | Tang Kevin, Tang Capital Management Llc | 10% Owner | P · Purchase | Indirect | 116,671 | $3.56 | $415K | Form 4 |
FULC insider trading FAQ
Are insiders buying FULC stock?
Yes. In the last 90 days, Fulcrum Therapeutics, Inc. insiders made 2 open-market purchases totaling $595K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading FULC?
Recent buyers: Tang Kevin, Tang Capital Management Llc.
Where does FULC insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.